Antiarthritic agents
Researchers have found that vagus nerve stimulation can modulate systemic inflammation and may represent a novel non-pharmacologic treatment modality for autoimmune diseases like rheumatoid arthritis. The study, conducted over a 36-month period, involved 14 patients with active RA who had previously failed an average of 4.8 different drugs. The
Antiarthritic agents
Research from India has revealed that a natural combination of turmeric and boswellia extracts, formulated in a product called Rhuleave-K, demonstrates significant anti-inflammatory effects and improves symptoms of mild-to-moderate osteoarthritis (OA). The study, published in Pharmacognosy Magazine, involved 100 participants who received either Rhuleave-K or a placebo for 12 weeks,
Antiarthritic agents
Osteoarthritis is a common joint condition correlated with aging, characterized by the gradual degradation of cartilage and ongoing low-level inflammation. Researchers from the School of Sciences have focused on the senescence-associated secretory phenotype (SASP) of chondrocytes, which plays a crucial function in driving the pathology of OA. The study aims
Antiarthritic agents
People in non-industrialized societies, such as hunter-gatherers and subsistence farmers, have a lower risk of osteoarthritis compared to those in industrialized societies. This reduced risk may be linked to dampened inflammatory activity, which is a key factor in osteoarthritis pathogenesis. Researchers from the University of New Mexico propose that four
Antiarthritic agents
Osteoarthritis is a common joint condition correlated with aging, characterized by the gradual degradation of cartilage and ongoing low-level inflammation. Researchers from the School of Sciences have focused on the senescence-associated secretory phenotype (SASP) of chondrocytes, which plays a crucial function in driving the pathology of OA. The study aims
Antiarthritic agents
A new study on osteoarthritis published in Scripta Medica highlights the growing trend of precision medicine in the field. According to the research, which analyzed 1,911 unique keywords and over 3,400 publications, the International Journal of Molecular Sciences emerged as the most productive journal in precision medicine for
Antiarthritic agents
Researchers from the University Rovira i Virgili have identified a novel microRNA (hsa-miR) panel that can predict cardiovascular risk in patients with rheumatoid arthritis. The study, conducted over an 8-year period, involved 235 patients with rheumatoid arthritis and found that the hsa-miR panel could accurately predict the progression of atherosclerotic
Antiarthritic agents
New research on rheumatoid arthritis (RA) has shed light on the vital role of regulatory B cells (Bregs) in the immune modulation of the disease. A study conducted by Jinan University Shenzhen People's Hospital found that the levels of CD19+CD24hiCD38hi Bregs in peripheral blood were significantly lower
Antiarthritic agents
Research at Razi University in Kermanshah, Iran, has shown that exercise interventions, including Nordic walking, can alleviate symptoms associated with knee osteoarthritis. A new study reports that a 6-week walking intervention program can mitigate symptoms of knee osteoarthritis, including pain, motor dysfunction, and diminished quality of life, in affected individuals.
Antiarthritic agents
Research conducted at the University of Massachusetts Boston has highlighted the significant impact of walking duration on arthritis-related joint pain among older adults. Investigators used data from the 2019 Behavioral Risk Factor Surveillance System (BRFSS) to analyze the association between walking duration and joint pain levels. The study found that
Antiarthritic agents
Research on the relationship between rheumatoid arthritis (RA) and metabolic dysfunction-associated steatotic liver disease (MASLD) has revealed a significant association between the two conditions. A population-based study conducted in Austria analyzed data from 6638 participants, including 187 individuals with physician-diagnosed RA. The study found that MASLD prevalence was higher in
Antiarthritic agents
Researchers from the University of British Columbia have developed and evaluated a behaviour change intervention to increase general practitioner (GP) referral of people with hip and knee osteoarthritis to community-based first-line care. The intervention, called REFER, aimed to overcome the barriers faced by GPs in referring patients to osteoarthritis management
